High eradication rates of Helicobacter pylori with a new sequential treatment |
| |
Authors: | Zullo A Vaira D Vakil N Hassan C Gatta L Ricci C De Francesco V Menegatti M Tampieri A Perna F Rinaldi V Perri F Papadìa C Fornari F Pilati S Mete L S Merla A Potì R Marinone G Savioli A Campo S M A Faleo D Ierardi E Miglioli M Morini S |
| |
Institution: | GI Unit, Nuovo Regina Margherita Hospital, Rome, Italy. zullo@tiscali.it |
| |
Abstract: | BACKGROUND: Eradication rates of Helicobacter pylori with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. AIM: To assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection. METHODS: One thousand and forty-nine dyspeptic patients were studied prospectively. H. pylori-infected patients were randomized to receive 10-day sequential therapy rabeprazole (40 mg daily) plus amoxicillin (1 g twice daily) for the first 5 days, followed by rabeprazole (20 mg), clarithromycin (500 mg) and tinidazole (500 mg) twice daily for the remaining 5 days] or standard 7-day therapy corrected] rabeprazole (20 mg), clarithromycin (500 mg) and amoxicillin (1 g) twice daily]. H. pylori status was assessed by histology, rapid urease test and 13C-urea breath test at baseline and 6 weeks or more after completion of treatment. RESULTS: Higher eradication rates were found with the sequential regimen compared to the standard regimen (intention-to-treat: 92% vs. 74%, P < 0.0001; per protocol: 95% vs. 77%, P < 0.0001). Higher eradication rates were also seen in patients with peptic ulcer disease and non-ulcer dyspepsia. In both treatments, compliance was similar (> 90%), as was the rate of side-effects, which were mild. CONCLUSIONS: This 10-day sequential treatment regimen achieves high eradication rates in peptic ulcer disease and non-ulcer dyspepsia. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|